- Description
- Benefits
- Risks
- Additional information
- Research
Description
LL-37 is a synthetic antimicrobial peptide derived from the human cathelicidin protein family. It is widely studied in laboratory environments for its role in innate immune response, antimicrobial activity, and cellular defence mechanisms.
In controlled research settings, LL-37 is investigated for its interaction with bacterial membranes, immune signalling pathways, and inflammatory response systems. It is of particular interest in studies exploring host defence peptides and immune system regulation.
Across Ireland and Europe, LL-37 is commonly used in research areas such as:
- Antimicrobial and antibacterial research
- Innate immune system signalling
- Inflammatory response modulation
- Skin and epithelial tissue defence mechanisms
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – LL-37
| Specification | Details |
|---|---|
| Product Name | LL-37 |
| Compound Type | Synthetic antimicrobial peptide |
| Origin | Derived from human cathelicidin (CAMP protein) |
| Functional Class | Antimicrobial and immune-modulating peptide |
| Mechanism of Action | Disrupts microbial membranes and modulates immune signalling |
| Biological Targets | Bacteria, immune cells, epithelial tissues |
| Amino Acid Length | 37 amino acids |
| Format | Lyophilised powder |
| Purity | Research-grade (high purity) |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Further Refrences: PubChem Entry
Researched Benefits & Focus Areas – LL-37
1. Antimicrobial Activity Research
LL-37 has been studied for:
- Disruption of microbial membranes in experimental models
- Activity against bacteria and other pathogens (research context)
- Investigation of host defence peptide mechanisms
Reference basis: Derived from microbiology and immunology research examining antimicrobial peptides and their role in innate immunity.
2. Innate Immune System Modulation
Research has explored:
- Interaction with immune signalling pathways
- Regulation of cytokine production and immune response
- Role in host defence and immune activation
Reference basis: Based on biochemical studies investigating cathelicidin peptides and immune system signalling pathways.
3. Anti-Inflammatory & Immune Regulation
LL-37 is studied for:
- Modulation of inflammatory responses
- Influence on cytokine and immune signalling pathways
- Balance between pro-inflammatory and anti-inflammatory activity
Reference basis: Supported by research into immune system regulation and inflammatory signalling pathways.
4. Skin & Epithelial Defence Research
- Studied in skin biology and wound environment models
- Explored in epithelial barrier protection research
- Investigated for cellular defence mechanisms
Reference basis: Derived from research into antimicrobial peptides in skin and epithelial tissue function.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – LL-37
1. Immune System Overactivation
- May strongly influence immune signalling pathways
- Potential for excessive inflammatory response in models
Reference basis: Based on studies examining immune activation and cytokine regulation by antimicrobial peptides.
2. Cytotoxicity in Experimental Conditions
- High concentrations may affect cell viability in vitro
- Requires controlled dosing in laboratory studies
Reference basis: Derived from research into antimicrobial peptide concentration-dependent effects on cells.
3. Complex Immune Interactions
- Interacts with multiple immune pathways
- Potential for variable outcomes depending on experimental conditions
Reference basis: Based on studies highlighting complexity of immune signalling systems.
4. Limited Long-Term Research
- Lack of extensive long-term data
- Primarily studied in preclinical and laboratory environments
Reference basis: Reflects the current stage of LL-37 research.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
Related Products
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS